These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6488414)

  • 1. Synthesis and biological activities of bioisosteric O-carba-analogues of platelet activating factor (PAF).
    Nakamura N; Miyazaki H; Ohkawa N; Koike H; Sada T; Asai F; Kobayashi S
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2452-5. PubMed ID: 6488414
    [No Abstract]   [Full Text] [Related]  

  • 2. Analogues of platelet activating factor. 4. Some modifications of the phosphocholine moiety.
    Wissner A; Schaub RE; Sum PE; Kohler CA; Goldstein BM
    J Med Chem; 1986 Mar; 29(3):328-33. PubMed ID: 3950913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogues of platelet activating factor (PAF). 2. Some modifications of the glycerine backbone.
    Wissner A; Schaub RE; Sum PE; Kohler CA; Goldstein BM
    J Med Chem; 1985 Sep; 28(9):1181-7. PubMed ID: 4032422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogues of platelet activating factor. 3. Replacement of the phosphate moiety with a sulfonylbismethylene group.
    Wissner A; Kohler CA; Goldstein BM
    J Med Chem; 1985 Sep; 28(9):1365-7. PubMed ID: 4032438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
    Takatani M; Yoshioka Y; Tasaka A; Terashita Z; Imura Y; Nishikawa K; Tsushima S
    J Med Chem; 1989 Jan; 32(1):56-64. PubMed ID: 2909744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical synthesis and physiological activity of sulfonium analogues of platelet activating factor.
    Kates M; Adams GA; Blank ML; Snyder F
    Lipids; 1991 Dec; 26(12):1095-101. PubMed ID: 1819693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and pulmonary activity of platelet-activating factor (PAF-acether) and its derivatives.
    Berti F; Ferri V; Pallavicini M; Pretolani M; Tremoli E; Valoti E; Villa L
    Pharmacol Res Commun; 1986 Jun; 18(6):557-62. PubMed ID: 3749244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.
    Heymans F; Steiner E; Jouquey S; Godfroid JJ
    J Lipid Mediat; 1989; 1(5):303-12. PubMed ID: 2562436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres.
    Wichrowski B; Jouquey S; Broquet C; Heymans F; Godfroid JJ; Fichelle J; Worcel M
    J Med Chem; 1988 Feb; 31(2):410-5. PubMed ID: 3339611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactone and cyclic ether analogues of platelet-activating factor. Synthesis and biological activities.
    Miyazaki H; Ohkawa N; Nakamura N; Ito T; Sada T; Oshima T; Koike H
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2379-90. PubMed ID: 2605681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and proaggregatory activity of 1-O-(2-methyloctadecyl)-2-O-acetyl-rac-glycero-3-phosphocholine.
    Schmid B; Ostermann G; Kertscher HP
    Chem Phys Lipids; 1991 Nov; 60(1):77-82. PubMed ID: 1813180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin induces non-enzymatic formation of platelet-activating factor from lyso platelet-activating factor.
    Mabuchi-Itoh K; Sugiura T; Cheng NN; Waku K
    FEBS Lett; 1993 Oct; 332(3):233-6. PubMed ID: 8405463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets.
    Hofmann B; Ostermann G; Kertscher HP; Till U
    Thromb Res; 1988 Feb; 49(4):415-23. PubMed ID: 3381200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activity of fluorine-modified platelet activating factors.
    Fujita K; Kobayashi S; Kudo I; Inoue K; Nojima S; Ohno M; Kobayashi Y; Odagiri M; Taguchi T
    Chem Pharm Bull (Tokyo); 1987 Feb; 35(2):647-53. PubMed ID: 3594676
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis of 1-(1-alkenyl)-2-acetyl-sn-glycero-3-phosphocholines, the aldehyded analogs of platelet activating factor].
    Gordeev KIu; Serebrennikova GA; Evstigneeva RP
    Bioorg Khim; 1987 Jan; 13(1):109-12. PubMed ID: 3566815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipids chiral at phosphorus. Synthesis and stereospecificity of phosphorothioate analogues of platelet-activating factor.
    Rosario-Jansen T; Jiang RT; Tsai MD; Hanahan DJ
    Biochemistry; 1988 Jun; 27(13):4619-24. PubMed ID: 3167004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New total synthesis and high resolution 1H NMR spectrum of platelet-activating factor, its enantiomer and racemic mixtures.
    Heymans F; Michel E; Borrel MC; Wichrowski B; Godfroid JJ; Convert O; Coeffier E; Tence M; Benveniste J
    Biochim Biophys Acta; 1981 Nov; 666(2):230-7. PubMed ID: 7306563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and platelet-activating factor (PAF)-antagonistic activities of trisubstituted piperazine derivatives.
    Fukushi H; Mabuchi H; Terashita Z; Nishikawa K; Sugihara H
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):551-9. PubMed ID: 8004700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An enantioselective synthesis of platelet-activating factors, their enantiomers, and their analogues from D- and L-tartaric acids.
    Ohno M; Fujita K; Nakai H; Kobayashi S; Inoue K; Nojima S
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):572-82. PubMed ID: 4017109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.